Medidata and Japan Pharmaceutical Manufacturers Association Collaborate on New Research Aimed at Streamlining Clinical Trial Costs Across Japan

Business News
Print
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced a research collaboration with the Japan Pharmaceutical Manufacturers Association (JPMA), a non-profit organization dedicated to developing innovative pharmaceuticals to improve the health and welfare of people worldwide. JPMA’s research initiative—which leveraged Medidata’s cloud-based technology and proprietary database of industry benc

imageimage
image

Read more